✦ LIBER ✦

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells

✍ Scribed by Brian M. Olson; Douglas G. McNeel

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 656 KB
Volume: 60
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-011-0987-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-specific CD8+ T lymphocytes derive

Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines

✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge

Detection of circulating tumor cells in

Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer

✍ Michael C. Mitas; Uzair B. Chaudhary; David T. Marshall; Sebastiano Gattoni-Cell 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

## Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer To the Editor: The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has attracted a great deal of attention among invest